Anavex Life Sciences (AVXL) Other Non-Current Assets (2016 - 2018)

Anavex Life Sciences (AVXL) reported Other Non-Current Assets of $52396.0 for Q3 2018, little changed on a YoY basis from $52396.0 in Q3 2017, and little changed sequentially from $52396.0 in Q2 2018.

Anavex Life Sciences (AVXL) Other Non-Current Assets (2016 - 2018) Analysis & Trends

Anavex Life Sciences (AVXL) has 3 years of Other Non-Current Assets data on file, last reported at $52396.0 in Q3 2018.

  • For the quarter ending Q3 2018, Other Non-Current Assets changed 0.0% year-over-year to $52396.0; the trailing twelve-month figure through Sep 2018 stood at $52396.0 (changed 0.0% YoY), and the FY2018 full-year result was $52396.0, changed 0.0% from the prior year.
  • Other Non-Current Assets held at $52396.0 in Q3 2018, from $52396.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $52396.0 in Q3 2016 to a low of $52396.0 in Q3 2016.
  • A 3-year average of $52396.0 and a median of $52396.0 in 2016 frame the typical range for Other Non-Current Assets.
  • Peak annual rise in Other Non-Current Assets reached 0.0% in 2017, while the deepest fall reached 0.0% in 2017.
  • Tracing AVXL's Other Non-Current Assets over 3 years: stood at $52396.0 in 2016, then changed by 0.0% to $52396.0 in 2017, then changed by 0.0% to $52396.0 in 2018.
  • Business Quant data shows AVXL's Other Non-Current Assets at $52396.0 in Q3 2018, $52396.0 in Q2 2018, and $52396.0 in Q1 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 66,681.27 Bn 66,680.98 Bn - 1.02 Mn
2 Nanobiotix 1,946.26 Bn 1,946.20 Bn - -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn - 60,000.00
4 BeOne Medicines 473.25 Bn 468.46 Bn 1.35 Bn 104.24 Mn
5 Vertex Pharmaceuticals 123.17 Bn 115.92 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 69.54 Bn 60.79 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 63.20 Bn 63.20 Bn - 289.41 Mn
8 Argenx Se 56.91 Bn 51.72 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 38.23 Bn 38.23 Bn - 14.48 Mn
10 Anavex Life Sciences 222.13 Mn 90.38 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2018 52,396.00
Jun 30, 2018 52,396.00
Mar 31, 2018 52,396.00
Dec 31, 2017 52,396.00
Sep 30, 2017 52,396.00
Jun 30, 2017 52,396.00
Sep 30, 2016 52,396.00